Cardiology Letters 2023, 32(4):229-234
Comment on 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice
- 1 II. kardiologickej klinika UPJŠ LF a VÚSCH, a. s. Košice
- 2 I. kardiologická klinika UPJŠ LF a VÚSCH, a. s., Košice a Centra preventívnej a športovej kardiológie VÚSCH, a. s. Košice
- 3 Ústav výživy, FOaZOŠ a Koordinačného centra pre familiárne hyperlipoproteinémie, Slovenská zdravotnícka univerzita v Bratislave, Slovenská republika
Published: April 1, 2023 Show citation
References
- Massimo F, Piepoli MF, Hoes AW, Agewall S, et al. Authors/Task Force Members; Additional Contributor. 2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts) Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR). Eur Heart J 2016;37:2315-2381.
Go to original source... - Williams B, Mancia G, Spiering W, et al. ESC Scientific Document Group. 2018 ESC/ESH Guidelines for the management of arterial hypertension. Eur Heart J2018;39:3021-3104. Go to original source...
- Cosentino F, Grant PJ, Aboyans V, et al. ESC Scientific Document Group. 2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD. Eur Heart J 2020;41:255-323. Go to original source...
- Authors/Task Force Members; ESC Committee for Practice Guidelines (CPG); ESC National Cardiac Societies. 2019 ESC/ EAS guidelines for the management of dyslipidaemias: Lipid modification to reduce cardiovascular risk. Atherosclerosis. 2019;290:140-205. Go to original source...
- Pelliccia A, Sharma S, Gati S, et al. 2020 ESC Guidelines on sports cardiology and exercise in patients with cardiovascular disease: The Task Force on sports cardiology and exercise in patients with cardiovascular disease of the European Society of Cardiology (ESC). Eur Heart J 2021;42:17-96. Go to original source...
- Jakubová M, Porubän T, Studenčan M, et al. Náhla srdcová smrť u športovcov a možnosti jej prevencie v podmienkach Slovenska ako verejno-zdravotnícky problém / Sudden cardiac death in athletes and its prevention in Slovakia - a public health issue. Cardiology Lett. 2022;31:131-135.
- Studencan M, Pella D, Bramlage P, et al. Clinical characteristics and management of hyperlipoproteinemia in patients with chronic coronary heart disease in Slovakia. Arch Med Sci 2021. Dostupné z DOI: <https://doi.org/10.5114/aoms/122017>. Go to original source...
- Tóth Š, Pella D. Ako sme na tom s dosahovaním cieľových hladín LDL-cholesterolu na Slovensku u vysokorizikovej populácie: retrospektívna štúdia. Atheroreview 2022;7:110-115.
- Banach M, Penson PE, Vrablik M, et al. Optimal use of lipid-lowering therapy after acute coronary syndromes: A Position Paper endorsed by the International Lipid Expert Panel (ILEP). Pharmacol Res. 2021;166:105499. doi 10.1016/j.phrs.2021.105499. Epub 2021 Feb 17. Go to original source...
- Tokgozoglu L, Torp-Pedersen C. Redefining cardiovascular risk prediction: is the crystal ball clearer now ? Eur Heart J 2021;42:2468-2471. Go to original source...
- Pella D, Tóth Š, Paralič J, et al. The possible role of machine learning in detection of increased cardiovascular risk patients - KSC MR Study (design). Arch Med Sci 2020. doi: https://doi.org/10.5114/aoms.2020.99156. Go to original source...